Treatment of attention deficit hyperactivity disorder in adults

@article{Greenfield2005TreatmentOA,
  title={Treatment of attention deficit hyperactivity disorder in adults},
  author={Brian Greenfield and Lily Hechman},
  journal={Expert Review of Neurotherapeutics},
  year={2005},
  volume={5},
  pages={107 - 121}
}
A number of medication and psychologic treatment options for adults with attention deficit hyperactivity disorder have become available during the past 5 years, while others are under investigation. This review describes the safety and effectiveness of the stimulants (i.e., methylphenidate and dexedrine), and particularly the newer long-acting stimulants (i.e., Concerta® and Adderall XR®) in the treatment of this population. Some nonstimulant/nonantidepressants, particularly atomoxetine, have… Expand
Pharmacological treatment of attention-deficit/hyperactivity disorder in adults
TLDR
The safety and efficacy of medications for treating the core symptoms, psychosocial features and cognitive dysfunctions associated with adult ADHD are described. Expand
Pharmacological and clinical dilemmas of prescribing in co‐morbid adult attention‐deficit/hyperactivity disorder and addiction
The present article reviews whether available efficacy and safety data support the pharmacological treatment of adult attention‐deficit/hyperactivity disorder (ADHD) in patients with concurrentExpand
Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria change
TLDR
The findings show that both diagnosis and treatment of adult ADHD remains inadequate despite the change in reimbursement criteria, and improving awareness ofadult ADHD among both the public and the professionals is essential to increase its chances of diagnosis andtreatment. Expand
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis
TLDR
There were few differences among individual medications, although atomoxetine was associated with improved patient-reported clinical response and quality of life compared with placebo, and the choice between ADHD pharmacotherapies may depend on individual patient considerations. Expand
Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
TLDR
Sustained-release methylphenidate or sustained-release bupropion did not provide a clear advantage over placebo in reducing ADHD symptoms or additional cocaine use in methadone-maintained patients. Expand
A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
TLDR
This review focuses on the pathophysiology, etiology, and treatment of ADHD and details the adverse effects and drug interaction profiles of the drugs used to treat it. Expand
Hyperfocusing as a dimension of adult attention deficit hyperactivity disorder.
TLDR
Hyperfocusing is higher in adult ADHD and there was no difference between stimulant-naive patients or patients on stimulant use, which can be defined as a separate dimension of adult ADHD. Expand
Performance Enhancing, Non-Prescription Use of Ritalin
TLDR
This minireview discusses psychopharmacological and behavioral aspects, and outline neurochemical mechanisms that may provoke Ritalin abuse, addiction and adverse effects compared to amphetamines and cocaine. Expand
Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder
TLDR
In adults studied in the AWE, medium-to-large model-based effect sizes were maintained from 2 to 14 hours postdose, on a performance-based measure of productivity, suggesting participants experienced improvement in sustained attention throughout the day and into the evening hours. Expand
Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients
TLDR
Performance on tests of processing speed were improved following the 45 mg condition and the largest effects were observed on the Symbol Digit Modalities Test, which measures visual processing speed and working memory. Expand
...
1
2
...

References

SHOWING 1-10 OF 67 REFERENCES
Antidepressants in the treatment of attention-deficit/hyperactivity disorder.
  • C. Popper
  • Psychology, Medicine
  • The Journal of clinical psychiatry
  • 1997
TLDR
Antidepressants differ in their effectiveness for treating attention-deficit/hyperactivity disorder (ADHD) in adults and children, and psychostimulants remain the treatment of choice because of their unique effect on attention. Expand
A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
  • E. Higgins
  • Medicine
  • The Journal of family practice
  • 1999
TLDR
Antidepressants may offer a safe first-line treatment for adults with ADHD and controlled studies suggest that desipramine (an antidepressant) may be as effective as methylphenidate (a stimulant) for improving symptoms of adult ADHD. Expand
A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
TLDR
Antidepressants may offer a safe first-line treatment for adults with ADHD and controlled studies suggest that desipramine (an antidepressant) may be as effective as methylphenidate (a stimulant) for improving symptoms of adult ADHD. Expand
Psychotherapy of attention deficit hyperactivity disorder in adults
TLDR
A structured skill training program particularly tailored for adult patients with ADHD, based on the principles of cognitive-behavioral treatment for borderline personality disorder developed by M. Linehan, resulted in positive outcomes in that patients improved on all psychometric scales. Expand
How High a Dose of Stimulant Medication in Adult Attention Deficit Hyperactivity Disorder?
TLDR
The clinical and experimental data justify the use of chronic low-dose stimulant treatment of ADHD in adults, with the recommended upper limit of dose being 1 mg/kg for methylphenidate and 0.5 mg/ kg for dexamphetamine. Expand
Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review.
TLDR
The literature appears to support the use of robust doses of both stimulants and antidepressants for ADHD in adults, and controlled studies applying stringent diagnostic criteria and outcome methodology are necessary to define the range of pharmacotherapeutic options. Expand
Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder.
TLDR
Adderall may be an effective agent for the treatment of adult forms of ADHD, with positive responses occurring at relatively low doses, at least for some individuals, but it may precipitate anxiety in vulnerable individuals. Expand
Psychosocial treatments for adults with attention-deficit/hyperactivity disorder.
TLDR
Some ways in which a history of failure experiences can enhance negative affect and cognitive avoidance and further impair attentional and organizational abilities associated with ADHD are discussed. Expand
A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.
TLDR
The results suggest a therapeutic role for bupropion in the armamentarium of agents for ADHD in adults, while further validating the continuity of pharmacological responsivity of ADHD across the lifespan. Expand
Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD).
TLDR
Results indicate the need for a longer clinical trial and a comparison with other stimulants in adult ADHD treatment, and indicate significant clinician-rated global improvement, self-rated vigor and concentration, and improved performance on chronometric measures of attention and timing accuracy. Expand
...
1
2
3
4
5
...